
### [MONDO:0019010](http://purl.obolibrary.org/obo/MONDO_0019010)
**Label:** congenital isolated hyperinsulinism

**Subclasses:** [MONDO:0012382](http://purl.obolibrary.org/obo/MONDO_0012382) (hyperinsulinemic hypoglycemia, familial, 4), [MONDO:0017188](http://purl.obolibrary.org/obo/MONDO_0017188) (Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency), [MONDO:0019333](http://purl.obolibrary.org/obo/MONDO_0019333) (autosomal recessive hyperinsulinism due to SUR1 deficiency), [MONDO:0009278](http://purl.obolibrary.org/obo/MONDO_0009278) (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), [MONDO:0012396](http://purl.obolibrary.org/obo/MONDO_0012396) (exercise-induced hyperinsulinism), [MONDO:0011153](http://purl.obolibrary.org/obo/MONDO_0011153) (hyperinsulinemic hypoglycemia, familial, 2), [MONDO:0019334](http://purl.obolibrary.org/obo/MONDO_0019334) (autosomal recessive hyperinsulinism due to Kir6.2 deficiency), [MONDO:0017185](http://purl.obolibrary.org/obo/MONDO_0017185) (autosomal dominant hyperinsulinism due to Kir6.2 deficiency), [MONDO:0019265](http://purl.obolibrary.org/obo/MONDO_0019265) (Diazoxide-resistant focal hyperinsulinism), [MONDO:0017184](http://purl.obolibrary.org/obo/MONDO_0017184) (autosomal dominant hyperinsulinism due to SUR1 deficiency), [MONDO:0017187](http://purl.obolibrary.org/obo/MONDO_0017187) (Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency), [MONDO:0017186](http://purl.obolibrary.org/obo/MONDO_0017186) (Diazoxide-resistant hyperinsulinism), [MONDO:0017183](http://purl.obolibrary.org/obo/MONDO_0017183) (hyperinsulinism due to UCP2 deficiency), [MONDO:0011717](http://purl.obolibrary.org/obo/MONDO_0011717) (hyperinsulinism-hyperammonemia syndrome), [MONDO:0011236](http://purl.obolibrary.org/obo/MONDO_0011236) (hyperinsulinism due to glucokinase deficiency), [MONDO:0016988](http://purl.obolibrary.org/obo/MONDO_0016988) (hyperinsulinism due to HNF4A deficiency), [MONDO:0015624](http://purl.obolibrary.org/obo/MONDO_0015624) (Diazoxide-sensitive diffuse hyperinsulinism), [MONDO:0017935](http://purl.obolibrary.org/obo/MONDO_0017935) (hyperinsulinism due to HNF1A deficiency), [MONDO:0015625](http://purl.obolibrary.org/obo/MONDO_0015625) (Diazoxide-resistant diffuse hyperinsulinism), 

**Corr. equiv. classes:** [Orphanet:79644](http://www.orpha.net/ORDO/Orphanet_79644), [OMIM:602485](http://purl.obolibrary.org/obo/OMIM_602485), [Orphanet:35878](http://www.orpha.net/ORDO/Orphanet_35878), [OMIM:601820](http://purl.obolibrary.org/obo/OMIM_601820), [OMIM:609975](http://purl.obolibrary.org/obo/OMIM_609975), [Orphanet:263455](http://www.orpha.net/ORDO/Orphanet_263455), [Orphanet:324575](http://www.orpha.net/ORDO/Orphanet_324575), [Orphanet:165985](http://www.orpha.net/ORDO/Orphanet_165985), [OMIM:610021](http://purl.obolibrary.org/obo/OMIM_610021), [Orphanet:276603](http://www.orpha.net/ORDO/Orphanet_276603), [OMIM:231530](http://purl.obolibrary.org/obo/OMIM_231530), [Orphanet:165988](http://www.orpha.net/ORDO/Orphanet_165988), [Orphanet:276556](http://www.orpha.net/ORDO/Orphanet_276556), [Orphanet:276575](http://www.orpha.net/ORDO/Orphanet_276575), [Orphanet:71212](http://www.orpha.net/ORDO/Orphanet_71212), [Orphanet:276598](http://www.orpha.net/ORDO/Orphanet_276598), [OMIM:606762](http://purl.obolibrary.org/obo/OMIM_606762), [Orphanet:276585](http://www.orpha.net/ORDO/Orphanet_276585), [Orphanet:79298](http://www.orpha.net/ORDO/Orphanet_79298), [Orphanet:79299](http://www.orpha.net/ORDO/Orphanet_79299), [Orphanet:165991](http://www.orpha.net/ORDO/Orphanet_165991), [Orphanet:276580](http://www.orpha.net/ORDO/Orphanet_276580), [Orphanet:79643](http://www.orpha.net/ORDO/Orphanet_79643), 

**Class expressions from DL-Learner:**

- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 59.33%
- [HP:0000842](http://purl.obolibrary.org/obo/HP_0000842) (Hyperinsulinemia) and [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 59.33%
- [HP:0000825](http://purl.obolibrary.org/obo/HP_0000825) (Hyperinsulinemic hypoglycemia) and [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 59.33%
- [HP:0001520](http://purl.obolibrary.org/obo/HP_0001520) (Large for gestational age) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 59.33%


